This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Buy Stocks for June 22nd
by Zacks Equity Research
ADNT, CLR, MTZ, PIPR, and MT have been added to the Zacks Rank #1 (Strong Buy) List on June 22, 2021.
Lear (LEA) Fails to Maintain Momentum Despite Q1 Earnings Beat
by Zacks Equity Research
Lear (LEA) envisions full-year net sales between $20.3 billion and $21.1 billion.
Magna (MGA) Inches Up 4% Since Q1 Earnings & Sales Beat
by Zacks Equity Research
Magna (MGA) now expects full-year revenues in the band of $40.2-$41.8 billion, up from the previous forecast of $40-$41.6 billion.
Adient (ADNT) Q2 Earnings Beat on EMEA & Asia Markets Strength
by Zacks Equity Research
Adient (ADNT) projects free cash flow in the band of $50-$150 million for fiscal 2021.
Adient (ADNT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 94.92% and 7.84%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Oshkosh (OSK) Up 5.4% Since Q2 Earnings and Revenue Beat
by Zacks Equity Research
Oshkosh (OSK) expects fiscal 2021 adjusted EPS in the band of $6.35-$6.85.
Allison (ALSN) Down Despite Q1 Earnings Beat, Raised '21 View
by Zacks Equity Research
Allison Transmission (ALSN) fails to impress investors despite a comprehensive beat in the last reported quarter and raised full-year 2021 guidance.
Earnings Preview: Adient (ADNT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex's (GNTX) Q1 Earnings & Sales Lag Estimates, Rise Y/Y
by Zacks Equity Research
Gentex (GNTX) envisions 2021 net sales in the band of $1.94-$2.02 billion, indicating an increase from 2020 revenues of $1.68 billion.
Business Expansion to Drive Adient (ADNT) Amid Global Chip Crunch
by Zacks Equity Research
Adient's (ADNT) focus on securing new businesses will likely help it overcome the macro hurdles.
Auto Stock Roundup: GM-SolidEnergy Deal, ADNT's Yanfeng JV Update & More
by Rimmi Singhi
While General Motors (GM) collaborates with SolidEnergy Systems to level up its battery technology, Adient (ADNT) is set to terminate its Yanfeng JV in China for $1.5 billion.
Adient (ADNT) Surges 17.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Adient (ADNT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Autoliv, Inc. (ALV) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Autoliv, Inc. (ALV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Adient (ADNT) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
Adient (ADNT) Up 7.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Adient (ADNT) Stock Outpacing Its Auto-Tires-Trucks Peers This Year?
by Zacks Equity Research
Is (ADNT) Outperforming Other Auto-Tires-Trucks Stocks This Year?
6 Low Price-to-Book Stocks to Buy in March for High Returns
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects. PVH Corp. (PVH), Honda Motor (HMC), Adient (ADNT), Owens Corning (OC), Conns (CONN) and Goldman Sachs (GS) are good stocks to add.
Is Adient (ADNT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Magna (MGA) Up 15% Since Solid Q4 Earnings & Robust '21 View
by Zacks Equity Research
Magna (MGA) expects 2021 revenues in the band of $40-$41.6 billion, implying a rise from $32.6 million recorded in 2020.
Allison Transmission (ALSN) Down 8.5% Since Q4 Earnings Miss
by Zacks Equity Research
Allison Transmission (ALSN) projects net sales for 2021 in the range of $2,265-$2,415 million, indicating an increase from $2,081 million recorded in 2020.
What's in the Offing for Hyliion (HYLN) This Earnings Season?
by Zacks Equity Research
Positive impact of Hyliion's (HYLN) combination with Tortoise Acquisition and use of latest technology are likely to have fueled the company's Q4 performance.
Is a Beat in Store for Magna (MGA) This Earnings Season?
by Zacks Equity Research
Robust growth in Body Exteriors & Structures, Power Vision and Complete Vehicles segments during the October-December period likely to reflect on Magna's (MGA) Q4 results.
5 Low Price-to-Book Stocks for Value Investors
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
American Axle (AXL) Q4 Earnings & Sales Top Estimates, Up Y/Y
by Zacks Equity Research
American Axle (AXL) projects full-year 2021 revenues of $5.3-$5.5 billion and adjusted EBITDA of $850-$925 million.
Are Investors Undervaluing Adient (ADNT) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.